Navidea biopharmaceuticals appoints thomas forest farb-horch and agnieszka winkler to the board of directors

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of thomas forest farb-horch and agnieszka winkler to its board of directors, effective october 7, 2021, each with a three-year term ending concurrently with the company's 2024 annual stockholders' meeting. thomas forest farb-horch has over three decades
NAVB Ratings Summary
NAVB Quant Ranking